Changes in innate and adaptive immunity over the first year after the onset of type 1 diabetes

[11] Leete P(2008)Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes Clin Immunol 31 959-969

[12] Nguyen V(2018)Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls J Pediatr Endocrinol Metab 19 963-971

[13] Krogvold L(2018)Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: a longitudinal study Pediatr Diabetes 166–167 72-80

[14] Wiberg A(2016)A pilot study showing associations between frequency of CD4+memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes Clin Immunol 42 S13-S28

[15] Edwin B(2019)2. Classification and diagnosis of diabetes: Standards of medical care in diabetes Diabetes Care 31 165-171

[16] Willcox A(2014)The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus Diabet Med 32 1384-1390

[17] Richardson SJ(2009)New definition for the partial remission period in children and adolescents with type 1 diabetes Diabetes Care 38 589-601

[18] Bone AJ(2018)Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation J Clin Immunol 49 523-531

[19] Oras A(2016)T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients Autoimmunity 153 49-55

[20] Peet A(2014)Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients Clin Immunol 161 144-149

[11] Leete P(2008)Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes Clin Immunol 31 959-969

[12] Nguyen V(2018)Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls J Pediatr Endocrinol Metab 19 963-971

[13] Krogvold L(2018)Immune cell and cytokine patterns in children with type 1 diabetes mellitus undergoing a remission phase: a longitudinal study Pediatr Diabetes 166–167 72-80

[14] Wiberg A(2016)A pilot study showing associations between frequency of CD4+memory cell subsets at diagnosis and duration of partial remission in type 1 diabetes Clin Immunol 42 S13-S28

[15] Edwin B(2019)2. Classification and diagnosis of diabetes: Standards of medical care in diabetes Diabetes Care 31 165-171

[16] Willcox A(2014)The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus Diabet Med 32 1384-1390

[17] Richardson SJ(2009)New definition for the partial remission period in children and adolescents with type 1 diabetes Diabetes Care 38 589-601

[18] Bone AJ(2018)Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation J Clin Immunol 49 523-531

[19] Oras A(2016)T regulatory lymphocytes in type 1 diabetes: Impaired CD25 expression and IL-2 induced STAT5 phosphorylation in pediatric patients Autoimmunity 153 49-55

[20] Peet A(2014)Decreased dendritic cell numbers but increased TLR9-mediated interferon-alpha production in first degree relatives of type 1 diabetes patients Clin Immunol 161 144-149